{"id":1371253,"title":"DSEN Abstract: High potency statins and the risk of new diabetes - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-21","captureTimestamp":"2026-03-21T16:16:22.164000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/49225.html","snippet":"DSEN Abstract High potency statins and the risk of new diabetes This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Colin R. Dormuth, Kristian B. Filion, J. Michael Paterson, Matthew T. James, Gary F. Teare,…","rawSnapshotUrl":"/api/snapshots/raw/1371253","browseUrl":"https://replay.healtharchive.ca/job-8/20260321161622/https://cihr-irsc.gc.ca/e/49225.html#ha_snapshot=1371253","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}